USP19 Stabilizes TAK1 to Regulate High Glucose/Free Fatty Acid-induced Dysfunction in HK-2 Cells

Abstract

Objective

Obesity-induced kidney injury contributes to the development of diabetic nephropathy (DN). Here, we identified the functions of ubiquitin-specific peptidase 19 (USP19) in HK-2 cells exposed to a combination of high glucose (HG) and free fatty acid (FFA) and determined its association with TGF-beta-activated kinase 1 (TAK1).

Methods

HK-2 cells were exposed to a combination of HG and FFA. USP19 mRNA expression was detected by quantitative RT-PCR (qRT-PCR), and protein analysis was performed by immunoblotting (IB). Cell growth was assessed by Cell Counting Kit-8 (CCK-8) viability and 5-ethynyl-2′-deoxyuridine (EdU) proliferation assays. Cell cycle distribution and apoptosis were detected by flow cytometry. The USP19/TAK1 interaction and ubiquitinated TAK1 levels were assayed by coimmunoprecipitation (Co-IP) assays and IB.

Results

In HG+FFA-challenged HK-2 cells, USP19 was highly expressed. USP19 knockdown attenuated HG+FFA-triggered growth inhibition and apoptosis promotion in HK-2 cells. Moreover, USP19 knockdown alleviated HG+FFA-mediated PTEN-induced putative kinase 1 (PINK1)/Parkin pathway inactivation and increased mitochondrial reactive oxygen species (ROS) generation in HK-2 cells. Mechanistically, USP19 stabilized the TAK1 protein through deubiquitination. Importantly, increased TAK1 expression reversed the USP19 knockdown-mediated phenotypic changes and PINK1/Parkin pathway activation in HG+FFA-challenged HK-2 cells.

Conclusion

The findings revealed that USP19 plays a crucial role in promoting HK-2 cell dysfunction induced by combined stimulation with HG and FFAs by stabilizing TAK1, providing a potential therapeutic strategy for combating DN.

References

[1] Gupta S, Dominguez M, Golestaneh L. Diabetic Kidney Disease: An Update. Med Clin North Am, 2023, 107(4): 689-705

[2] Dagar N, Das P, Bisht P, et al.. Diabetic nephropathy: A twisted thread to unravel. Life Sci, 2021, 278: 119635

[3] Yang M, Chen W, He L, et al.. Intermittent Fasting-A Healthy Dietary Pattern for Diabetic Nephropathy. Nutrients, 2022, 14(19): 3995

[4] Opazo-Ríos L, Mas S, Marín-Royo G, et al.. Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities. Int J Mol Sci, 2020, 21(7): 2632

[5] Bayliss G, Weinrauch LA, D’Elia JA. Pathophysiology of obesity-related renal dysfunction contributes to diabetic nephropathy. Curr Diab Rep, 2012, 12(4): 440-446

[6] Chen SJ, Lv LL, Liu BC, et al.. Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease. Cell Prolif, 2020, 53(3): e12763

[7] Kitamura H. Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders. Int J Mol Sci, 2023, 24(4): 3219

[8] You Y, Wang H, Wang Q, et al.. Silencing USP19 alleviates cigarette smoke extract-induced mitochondrial dysfunction in BEAS-2B cells by targeting FUNDC1. Open Med (Wars), 2023, 18(1): 20230798

[9] Zhang X, Chen X, Qian F, et al.. Deubiquitinase USP19 modulates apoptotic calcium release and endoplasmic reticulum stress by deubiquitinating BAG6 in triple negative breast cancer. Clin Transl Med, 2023, 13(9): e1398

[10] Lei CQ, Wu X, Zhong X, et al.. USP19 Inhibits TNF-α- and IL-1β-Triggered NF-κB Activation by Deubiquitinating TAK1. J Immunol, 2019, 203(1): 259-268

[11] Liu T, Wang L, Liang P, et al.. USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy. Cell Mol Immunol, 2021, 18(10): 2431-2442

[12] Tian Z, Xu C, He W, et al.. The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP. Cancer Lett, 2023, 577: 216439

[13] Zhang J, van Dinther M, Thorikay M, et al.. Opposing USP19 splice variants in TGF-β signaling and TGF-β-induced epithelial-mesenchymal transition of breast cancer cells. Cell Mol Life Sci, 2023, 80(2): 43

[14] Coyne ES, Bedard N, Wykes L, et al.. Knockout of USP19 Deubiquitinating Enzyme Prevents Muscle Wasting by Modulating Insulin and Glucocorticoid Signaling. Endocrinology, 2018, 159(8): 2966-2977

[15] Coyne ES, Bédard N, Gong YJ, et al.. The deubiquitinating enzyme USP19 modulates adipogenesis and potentiates high-fat-diet-induced obesity and glucose intolerance in mice. Diabetologia, 2019, 62(1): 136-146

[16] Zhu Y, Gu L, Lin X, et al.. USP19 exacerbates lipogenesis and colorectal carcinogenesis by stabilizing ME1. Cell Rep, 2021, 37(13): 110174

[17] Ma M, Dang Y, Chang B, et al.. TAK1 is an essential kinase for STING trafficking. Mol Cell, 2023, 83(21): 3885-3903

[18] Mihaly SR, Ninomiya-Tsuji J, Morioka S. TAK1 control of cell death. Cell Death Differ, 2014, 21(11): 1667-1676

[19] Lan T, Jiang S, Zhang J, et al.. Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling. Hepatology, 2022, 76(1): 155-171

[20] Cao H, Lu J, Du J, et al.. TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice. Sci Rep, 2015, 5: 14593

[21] Wang Y, Mao Y, Zhang X, et al.. TAK1 may promote the development of diabetic nephropathy by reducing the stability of SnoN protein. Life Sci, 2019, 228: 1-10

[22] Wei TT, Yang LT, Guo F, et al.. Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy. Acta Pharmacol Sin, 2021, 42(2): 252-263

[23] Dogra S, Bandi S, Viswanathan P, et al.. Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma. Cancer Lett, 2015, 356(2): 953-961 Pt B

[24] Little AC, Kovalenko I, Goo LE, et al.. High-content fluorescence imaging with the metabolic flux assay reveals insights into mitochondrial properties and functions. Commun Biol, 2020, 3(1): 271

[25] Zhang Y, Liu P, Wen D, et al.. Regulation of Cervical Cancer Development by a Novel Circ_0000212/miR-1236-3p/GREM1 ceRNA Crosstalk. Mol Biotechnol, 2023, 65(12): 2086-2098

[26] Silvian LF. PINK1/Parkin Pathway Activation for Mitochondrial Quality Control - Which Is the Best Molecular Target for Therapy?. Front Aging Neurosci, 2022, 14: 890823

[27] Sherkhane B, Kalvala AK, Arruri VK, et al.. Renoprotective potential of myo-inositol on diabetic kidney disease: Focus on the role of the PINK1/Parkin pathway and mitophagy receptors. J Biochem Mol Toxicol, 2022, 36(6): e23032

[28] Cockram PE, Kist M, Prakash S, et al.. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ, 2021, 28(2): 591-605

[29] Li H, Wang Y, Su X, et al.. San-Huang-Yi-Shen Capsule Ameliorates Diabetic Kidney Disease through Inducing PINK1/Parkin-Mediated Mitophagy and Inhibiting the Activation of NLRP3 Signaling Pathway. J Diabetes Res, 2022, 2022: 2640209

[30] Zhu Y, Gu L, Lin X, et al.. P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis. Hepatology, 2023, 77(5): 1499-1511

[31] Wang Y, Zhao L, Qiu D, et al.. Effects of transforming growth factor beta-activated kinase 1 (TAK1) on apoptosis of HK-2 cells in the high glucose environment. Bioengineered, 2022, 13(3): 5880-5891

[32] Deng B, Song A, Zhang C. Cell-Cycle Dysregulation in the Pathogenesis of Diabetic Kidney Disease: An Update. Int J Mol Sci, 2023, 24(3): 2133